Kodiak Sciences Inc.

US$99.30As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:KODHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR 33.28%
Div yield —
ROE (368.37%)
Biotechnology
Beta (5Y) 1.98
PE TTM —
TSR TTM 447.86%
Mkt cap US$6.228B
ROIC (124.49%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$103
3.33%
(23.43%)
Hold 9|0|1|6|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
2.18
2.21
2.13
2.17
27.08%
16.59%
8.23%
11.45%
Revenue$M
635.2
671.0
666.6
680.1
9.26%
17.18%
10.79%
9.11%
Peers (US$6.228B)
Cap (US$)
PE
6.306B
—
6.210B
—
6.330B
124.2x
Capital
TTM
5Y
10Y
Leveragex
0.527
0.162
0.151
EBIT/Intx
0.687
0.130
0.132
Own earn%
(61.95)
(101.44)
(77.86)
Sh yield%
41.17
21.71
21.12
Owners
Insiders/Inst%
11.83
68.51
Short interest%
2.56
SBC / revenue%
0.50
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
22–32
$1 testx
—
Incr. ROIC%
2